Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Voxzogo (vosoritide) is a C-type natriuretic peptide (CNP) analog indicated to increase linear growth in children with achondroplasia who have open epiphyses (growth plates). Achondroplasia is the most common form of dwarfism caused by a mutation in the FGFR3 gene, which negatively regulates bone growth. Voxzogo works by directly targeting this pathway to promote endochondral ossification and bone elongation, thereby improving height velocity. It is the first and only approved therapy that addresses the underlying pathophysiology of achondroplasia.
| Fact Table | |
| Formula | C165H263N51O55S1 |
| License | US FDA (2021) |
| Bioavailability | Subcutaneous: ~65% |
| Legal status | Prescription only |
| Chemical Name | Vosoritide |
| Elimination half-life | 24 minutes |
| Dosage (Strength) | 0.4 mg, 0.56 mg, 1.2 mg lyophilized powder for injection |
| Pregnancy | Not recommended – no adequate data |
| Brands | Voxzogo |
| Protein binding | Low (peptide hormone) |
| PubChem CID | 121331120 |
| MedlinePlus | a622056 |
| ChEBI | Not assigned |
| ATC code | H01AX10 |
| DrugBank | DB14761 |
| KEGG | D12297 |
| Routes of administration | Subcutaneous injection |
Voxzogo is administered by subcutaneous injection once daily.
Injection sites (abdomen, thighs, upper arms) should be rotated to reduce risk of local reactions. Voxzogo should be administered at the same time each day, preferably in the evening. Treatment should be initiated and monitored by a healthcare provider experienced in managing pediatric growth disorders.
Active ingredient: vosoritide Inactive ingredients: mannitol, L-histidine, polysorbate 20, and hydrochloric acid (for pH adjustment). Reconstitution with sterile water for injection is required before administration.
Voxzogo is contraindicated in patients with:
Voxzogo may cause transient decreases in blood pressure; patients should be monitored for hypotension, particularly within 4 hours after injection. It is not indicated for other forms of short stature not related to achondroplasia. Epiphyseal status must be confirmed via radiologic assessment before initiating therapy. Use in combination with other growth-promoting treatments (e.g., growth hormone) has not been studied and is not recommended. Safety and effectiveness in patients under 6 months of age have not been established.
Common side effects may include:
Most adverse effects are mild to moderate in severity and self-limiting.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews